Controversy over generic substitution

R.E. Ferner, Warren Lenney, John F. Marriott

Research output: Contribution to journalArticle

Abstract

Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.
Original languageEnglish
Pages (from-to)1341-1343
Number of pages3
JournalBMJ
Volume340
Issue number7760
DOIs
Publication statusPublished - 1 Jun 2010

Fingerprint

Drug Substitution
Songbirds
Pharmacists
Medicine

Cite this

Ferner, R. E., Lenney, W., & Marriott, J. F. (2010). Controversy over generic substitution. BMJ, 340(7760), 1341-1343. https://doi.org/10.1136/bmj.c2548
Ferner, R.E. ; Lenney, Warren ; Marriott, John F. / Controversy over generic substitution. In: BMJ. 2010 ; Vol. 340, No. 7760. pp. 1341-1343.
@article{1afd770b14ed4c8a91c0bb0f0c994207,
title = "Controversy over generic substitution",
abstract = "Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.",
author = "R.E. Ferner and Warren Lenney and Marriott, {John F.}",
year = "2010",
month = "6",
day = "1",
doi = "10.1136/bmj.c2548",
language = "English",
volume = "340",
pages = "1341--1343",
journal = "BMJ",
issn = "0959-8138",
publisher = "BMJ Publishing Group",
number = "7760",

}

Ferner, RE, Lenney, W & Marriott, JF 2010, 'Controversy over generic substitution', BMJ, vol. 340, no. 7760, pp. 1341-1343. https://doi.org/10.1136/bmj.c2548

Controversy over generic substitution. / Ferner, R.E.; Lenney, Warren; Marriott, John F.

In: BMJ, Vol. 340, No. 7760, 01.06.2010, p. 1341-1343.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Controversy over generic substitution

AU - Ferner, R.E.

AU - Lenney, Warren

AU - Marriott, John F.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.

AB - Substitution of branded medicine with a generic equivalent is already common. Robin Ferner, Warren Lenney, and John Marriott argue that concerns about UK plans to let pharmacists make the decision are unwarranted.

UR - http://www.scopus.com/inward/record.url?scp=77953722299&partnerID=8YFLogxK

UR - http://www.bmj.com/content/340/bmj.c2548

U2 - 10.1136/bmj.c2548

DO - 10.1136/bmj.c2548

M3 - Article

AN - SCOPUS:77953722299

VL - 340

SP - 1341

EP - 1343

JO - BMJ

JF - BMJ

SN - 0959-8138

IS - 7760

ER -

Ferner RE, Lenney W, Marriott JF. Controversy over generic substitution. BMJ. 2010 Jun 1;340(7760):1341-1343. https://doi.org/10.1136/bmj.c2548